Curated News
By: NewsRamp Editorial Staff
August 11, 2026
Nano-X and Intel Optimize AI for On-Premise Medical Imaging
TLDR
- Nano-X Imaging gains an edge by enabling on-premise AI processing with Intel Core Ultra, reducing cloud dependency and boosting efficiency.
- Nanox AI optimized its imaging framework for Intel Core Ultra using OpenVINO, enabling local edge inference for CT scans while keeping data on-premise.
- Nanox's on-premise AI brings preventive care closer to patients, improving early detection of chronic conditions and enhancing healthcare accessibility.
- Nanox AI and Intel join forces to run medical imaging AI on local devices, promising faster insights without cloud reliance.
Impact - Why it Matters
This news matters because it represents a critical step towards making advanced medical imaging AI more accessible and secure. By enabling on-premise processing with Intel's optimized hardware, healthcare facilities can deploy AI tools without compromising patient data privacy or relying on constant cloud connectivity. This could lead to faster diagnoses, earlier detection of chronic diseases, and improved patient outcomes, particularly in settings with limited internet infrastructure. Moreover, it aligns with the broader shift towards edge computing in healthcare, potentially reducing costs and enhancing operational efficiency. For patients, this means more timely and accurate screenings; for providers, it offers a practical, scalable solution to integrate AI into routine workflows.
Summary
Nano-X Imaging Ltd. (NASDAQ: NNOX) has announced a significant advancement in medical imaging AI through its subsidiary, Nanox AI Ltd. The company has optimized its AI application framework for Intel Core Ultra processors using Intel's OpenVINO toolkit. This optimization enables healthcare facilities to deploy CT imaging AI applications on on-premise edge devices, ensuring that imaging data remains within their own infrastructure. The Nanox.AI solutions are designed to analyze routine CT scans to identify findings correlated with chronic conditions affecting cardiac, liver, and bone health. This development marks a step forward in bringing AI-enabled imaging insights closer to the point of care, reducing reliance on cloud connectivity, and facilitating deployment within existing hospital systems.
The optimized framework has successfully run inference on Intel Core Ultra-class hardware using OpenVINO, demonstrating its practicality for on-premise medical imaging AI processing. This approach supports local edge inference, which can enhance data security and reduce latency, while also enabling healthcare providers to leverage advanced AI without the need for extensive cloud infrastructure. Nanox's broader mission is to drive the world's transition to preventive healthcare by delivering an integrated medical imaging and healthcare services platform. The company combines affordable imaging hardware, AI-based solutions, cloud-based software, remote radiology access, health IT solutions, and a marketplace to enable earlier detection and improved clinical efficiency.
Nanox's ecosystem includes the Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis system; Nanox.AI, which augments routine CT interpretation; Nanox.CLOUD for secure data management; Nanox.MARKETPLACE and USARAD Holdings for remote radiology services; and Nanox Health IT for workflow solutions. By integrating these components, Nanox aims to lower barriers to adoption and expand the reach of medical imaging. For more details, visit the full press release at https://ibn.fm/pld2S and the company's website at https://www.nanox.vision/. BioMedWire, a specialized communications platform, distributed this news, highlighting its significance in the biotech and life sciences sectors.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Nano-X and Intel Optimize AI for On-Premise Medical Imaging
